previous compound ID: 2366 next compound
InChIKey: VPNYRYCIDCJBOM-UHFFFAOYSA-M
SMILES: C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "D Rotin" "JW Hanrahan" "B Kus" "E Matthes" "J Goepp" "SD Macknight" "GW Carlile" "DY Thomas" "R Robert"

chemical graph of compound 2366





CID is 11693
synonyms found at PubChem are:
GLYCOPYRROLATE, 596-51-0, glycopyrronium bromide, Glycopyrrolate bromide, Robinul, Gastrodyn, Asecryl, Nodapton, Tarodyl, Tarodyn, Glycopyrronii bromidum, Copyrrolate, Glycopyrronium, Cuvposa, AHR-504, ROBINUL FORTE, Bromuro de glicopirronio, Bromure de glycopyrronium, Robinal, NSC 250836, NSC 251251, NSC 251252, Seebri Neohaler, Seebri Breezhaler, AHR 504, NVA-237, Glycopyrronii bromidum [INN-Latin], EINECS 209-887-0, Glycopyrroni bromidum, Bromure de glycopyrronium [INN-French], Bromuro de glicopirronio [INN-Spanish], 3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate, NVA 237, Glycopyrrolate [USAN], Bromure de ritropirronio, Bromure de ritropirronium, 1,1-Dimethyl-3-hydroxypyrrolidinium bromide alpha-cyclopentylmandelate, 1-Methyl-3-pyrrolidyl alpha-phenylcyclopentaneglycolate methobromide, Ritropirronium bromide [INN], Robinul (TN), DSSTox_CID_3109, Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide, Glycopyrrolate (USP), DSSTox_RID_76878, DSSTox_GSID_23109, Seebri, Pyrrolidinium,1-dimethyl-, bromide, 3-(2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidinium Bromide, Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate, CPD000469282, SMR000469282, Glycopyrronium bromide (JAN/INN), AD-237, NSC250836, NSC251251, NSC251252, PT-001, 3-(erythro-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidiniumbromid, NCGC00179456-02, WLN: T5KTJ A1 A1 COVXQR&- AL5TJ &Q &E, C19H28BrNO3, Glycopyrrolate [USAN:USP], Lonhala Magnair, Pyrrolidinium,1-dimethyl-, bromide, .alpha.-cyclopentylmandelate, Mandelic acid, ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide, 53808-86-9, Cuvposa (TN), .beta.-1-Methyl-3-pyrrolidyl-.alpha.-cyclopentylmandelate methobromide, 1,1-Dimethyl-3-hydroxypyrrolidinium bromide .alpha.-cyclopentylmandelate, 1-Methyl-3-pyrrolidinyl .alpha.-phenylcyclopentaneglycolate methobromide, 3-Hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate, 3-Hydroxy-1,1-dimethylpyrrolidinium bromide-.alpha.-cyclopentylmandelate, Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate, (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate bromide, Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate (8CI), Seebri breezhaler (TN), AC1Q1RGS, CAS-596-51-0, GLYCOPYRRONE BROMIDE, AC1L1XX0, AC1LAW54, SCHEMBL41436, Glycopyrronium Bromide ,(S), MLS001424112, MLS002222301, CHEMBL1201027, DTXSID6023109, C19H28NO3, CHEBI:90972, MolPort-006-112-011, VPNYRYCIDCJBOM-UHFFFAOYSA-M, Glycopyrrolate, >=98% (HPLC), HMS1570E14, HMS2051P12, HMS2094A05, HMS2097E14, HMS2235F12, HMS3259P04, HMS3369F10, HMS3393P12, HMS3714E14, Pharmakon1600-01505753, [(3S)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide, BCP07110, CHF-5992, Tox21_113144, Tox21_113145, MFCD00072137, NSC759238, s4660, 3-(2-phenyl-2-cyclopentylglycoloyloxy)-1,1-dimethylpyrrolidinium bromide, AKOS015962136, Tox21_113144_1, CCG-101030, CCG-213543, CS-1763, NC00280, NC00694, NSC-250836, NSC-251251, NSC-251252, NSC-759238, RL04249, NCGC00179456-04, AC-23382, AN-46262, BC209826, HY-17465, OR315526, SAM001246629, SAM002589987, AB0010706, LS-138344, FT-0626787, G0392, ST24047338, D00540, SR-01000763650, I14-3643, Nodapton|||Robanul|||Robinul|||Tarodyl|||Tarodyn, SR-01000763650-3, 1-methyl-3-pyrrolidyl alpha-cyclopentylmandelate methobromide, Glycopyrrolate, United States Pharmacopeia (USP) Reference Standard, 1-methyl-3-pyrrolidyl alpha-phenyl-alpha-cyclopentylglycolate methobromide, Glycopyrronium bromide, European Pharmacopoeia (EP) Reference Standard, Glycopyrronium impurity N, European Pharmacopoeia (EP) Reference Standard, (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate bromide, 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide, 3-{[cyclopentyl(hydroxy)phenylacetyl]oxy}-1,1-dimethylpyrrolidin-1-ium bromide, alpha-cyclopentylmandelic acid ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide, erythro-3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate, erythro-3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate., Glycopyrronium for peak identification, European Pharmacopoeia (EP) Reference Standard, ZNYLRIGBNGHLRL-UHFFFAOYSA-N